This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs

Event Date: 02/06/2024
Location: Washington, DC
Subject: George Washington University Forum; A Conversation with FDA Commissioner Responding to Online Mis- and Disinformation and Increasing Trust in Public Institutions
FDA Participant/Group: N/A
Non FDA Participant/Group: Academia, media, and other invited guests

Event Date: 02/07/2024
Location: Virtual
Subject: Good Clinical Trials Collaborative Steering Group
FDA Participant/Group: MOHAMMED ELZARRAD;
Non FDA Participant/Group: Academia, industry, and government

Official Name: Namandjé N. Bumpus, Ph.D., Principal Deputy Commissioner

Event Date: 02/08/2024
Location: Virtual
Subject: National Council for Negro Women Meeting
FDA Participant/Group: KIMBERLEE TRZECIAK; LEAH HUNTER;
Non FDA Participant/Group: Representatives of the National Council for Negro Women

Official Name: Jim Jones, Deputy Commissioner for Human Foods

Event Date: 02/05/2024
Location: College Park, MD
Subject: Seafood Safety Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Lisa Wallenda Picard, Lisa Weddig, Robert DeHaan (National Fisheries Institute);

Event Date: 02/06/2024
Location: Washington, DC
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Staff and members of the National Association of State Departments of Agriculture

Event Date: 02/07/2024
Location: Washington, DC
Subject: National Association of State Departments of Agriculture's Winter Policy Conference; Speaker
FDA Participant/Group: N/A
Non FDA Participant/Group: Federal and state government agriculture officials

Event Date: 02/09/2024
Location: Virtual
Subject: Menu Labeling
FDA Participant/Group: HALLEY KROPA; CLAUDINE KAVANAUGH; REBECCA BUCKNER; JANESIA ROBBS; MEGAN VELEZ;
Non FDA Participant/Group: Christina LiPuma, Emily Friedman, Eva Greenthal, Matt Simon, Peter Lurie, Sarah Sorscher (Center for Science in the Public Interest);

Official Name: Kimberlee Trzeciak, Deputy Commissioner for Policy, Legislation, and International Affairs

Event Date: 02/08/2024
Location: Virtual
Subject: Alliance for a Stronger FDA Event; Fireside Chat
FDA Participant/Group: N/A
Non FDA Participant/Group: Steven Grossman (Alliance for a Stronger FDA); Emily Holubowich (American Heart Association); Phil Karsting (OFW Law); ;representatives of Alliance for a Stronger FDA

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Michael Rogers, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Leah Hunter, Associate Commissioner for External Affairs

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 02/06/2024
Location: Rockville, MD
Subject: Advancing the Development of Bespoke Gene Therapies
FDA Participant/Group: N/A
Non FDA Participant/Group: Several representatives from the Accelerating Medicines Partnership

Event Date: 02/07/2024
Location: San Diego, CA
Subject: We’re Organizing Research on Lysosomal Diseases (WORLD) Symposium; Keynote: Accelerating the Pace of Progress in Gene Therapy
FDA Participant/Group: N/A
Non FDA Participant/Group: Basic, translational and clinical researchers, patient advocacy groups, and clinician stakeholders

Event Date: 02/08/2024
Location: Bethesda, MD
Subject: Limb-Girdle Muscular Dystrophy Scientific Workshop; Speaker: Accelerating the Pace of Progress in Gene Therapy
FDA Participant/Group: N/A
Non FDA Participant/Group: Academic, research, industry, government, and patient stakeholders

Event Date: 02/09/2024
Location: Virtual
Subject: National PKU (phenylketonuria) Alliance; Breaking Through the Barriers to Advance Gene Therapies
FDA Participant/Group: N/A
Non FDA Participant/Group: Academic, research, and patient stakeholders

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Donald Prater, Acting Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

Event Date: 02/05/2024
Location: Panama City, Panama
Subject: Conference of Parties to the WHO Framework Convention on Tobacco Control
FDA Participant/Group: Several FDA/HHS staff
Non FDA Participant/Group: Several representatives of the Conference of Parties to the WHO Framework Convention on Tobacco Control

Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine

No Significant Event

Official Name: Tucker Patterson, Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event